Costs
AdvancedMD is 2015 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of the U.S. Department of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.
As a cloud technology, AdvancedMD is an all-inclusive product and service. In agreement to the AdvancedMD terms of service, the eligible professional pays a monthly service fee for a comprehensive product. This certified product-version requires a monthly service fee that enables e-Prescribing, computerized provider order entry, formulary checking, interaction checking, VDT (view/download/transmit), clinical information reconciliation, transmit transitions of care, patient education and secure messaging.
EHR CHPL Product Number:
15.04.04.2666.Adva.23.05.1.231213
AdvancedMD Mobile CHPL Product Number:
15.04.04.2666.AdvM.06.02.1.231120
| Real World Testing Plan 2024 | |
| Real World Testing Plan 2023 | Real-World Testing Results 2023 |
| Real World Testing Plan 2022 | Real-World Testing Results 2022 |
Multi-Factor Authentication in AdvancedMD & AdvancedMD Mobile
AdvancedMD offers free 2FA as an optional service to give you an extra layer of security that works in conjunction with the username and password by adding a second security code to your login verification that only you can access (such as receiving the code in your email account). We also offer a 2FA security code via an authenticator app on your smartphone. By setting 2FA system defaults, your practice administrator can require 2FA for your entire office, regardless of how many locations you have, as part of an increased security initiative. If you do not wish to globally mandate 2FA across your entire practice, individual users can choose to set up 2FA as part of their login process. Use your work (or personal) email account to request and get your security code. You can also get a security code by setting up an authenticator app on your smartphone. You can also use an authenticator app on your Smartphone. One example is Google Authenticator™.
AdvancedMD FHIR APIs
ONC has launched the 2015 Edition Cures Update with the new Standardized API for Patient and Population Services § 170.315(g)(10) criterion. To meet the requirements, AdvancedMD has implemented the FHIR API, Smart application support, and adopted all the required standards of authorization, authentication, token revocation, security, and privacy standards.
API Documentation
https://developer.advancedmd.com/fhir/apis
Service Base URL List
https://developer.advancedmd.com/fhir/base-urls
EHR certification criteria
Certification criteria:
170.315 (a)(1): Computerized Provider Order Entry (CPOE)
170.315 (a)(2): CPOE – Laboratory
170.315 (a)(3): CPOE – Diagnostic Imaging
170.315 (a)(4): Drug-Drug, Drug-Allergy Interaction Checks
170.315 (a)(5): Demographics
170.315 (a)(9): Clinical Decision Support
170.315 (a)(12): Family Health History
170.315 (a)(14): Implantable Device List
170.315 (b)(1): Transitions of Care
170.315 (b)(2): Clinical Information Reconciliation and Incorporation
170.315 (b)(3): Electronic Prescribing
170.315 (b)(10): EHI Export
170.315 (c)(1): Clinical Quality Measures – Record and Export
170.315 (c)(2): Clinical Quality Measures – Import and Calculate
170.315 (c)(3): Clinical Quality Measures – ReportV
170.315 (c)(4): Clinical Quality Measures – Filter
170.315 (d)(1): Authentication, Access Control, Authorization
170.315 (d)(2): Auditable Events and Tamper-Resistance
170.315 (d)(3): Audit Report(s)
170.315 (d)(4): Amendments
170.315 (d)(5): Automatic Access Time-out
170.315 (d)(6): Emergency Access
170.315 (d)(7): End-User Device Encryption
170.315 (d)(8): Integrity
170.315 (d)(9): Trusted Connection
170.315 (d)(11): Accounting of Disclosures
170.315 (d)(12): Encrypt Authentication Credentials
170.315 (d)(13): Multi-factor authentication
170.315 (e)(1): View, Download, and Transmit to 3rd Party
170.315 (e)(3): Patient Health Information Capture
170.315 (f)(1): Transmission to Immunization Registries
170.315 (g)(2): Automated Measure Calculation
170.315 (g)(3): Safety-Enhanced Design
170.315 (g)(4): Quality Management System
170.315 (g)(5): Accessibility-Centered Design
170.315 (g)(6): Consolidated CDA Creation
170.315 (g)(7): Application Access – Patient Selection
170.315 (g)(9): Application Access – All Data Request
170.315 (g)(10): Standardized API for Patient and Population Services
170.315 (h)(1): Direct Project
Clinical Quality Measures certified:
CMS2: Preventive Care and Screening: Screening for Depression and Follow-Up Plan
CMS22 Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented
CMS50 Closing the Referral Loop: Receipt of Specialist Report
CMS56: Functional Status Assessment for Total Hip Replacement
CMS65: Hypertension: Improvement in Blood Pressure
CMS66: Functional Status Assessment for Knee Replacement
CMS68 Documentation of Current Medications in the Medical Record
CMS69 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up
CMS74: Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
CMS75 Children who have dental decay or cavities
CMS82: Maternal Depression Screening
CMS90 Functional Status assessment for complex chronic conditions
CMS117 Childhood Immunization Status
CMS122 Diabetes: Hemoglobin A1C Poor Control
CMS124 Cervical Cancer Screening
CMS125 Breast Cancer Screening
CMS127 Pneumonia Vaccination status for older adults
CMS128: Anti-depressant Medication Management
CMS129: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS130 Colorectal Cancer Screening
CMS131 Diabetes: Eye Exam
CMS132: Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
CMS133: Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS134 Diabetes: Urine Protein Screening
CMS135: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS136: ADHD: Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication
CMS137: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
CMS138 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS139 Screening for Future Fall Risk
CMS142 Diabetic Retinopathy: Communication with the physician managing ongoing diabetes care
CMS143: Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS144: Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS145: Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)
CMS146 Appropriate Testing for children with Pharyngitis
CMS147 Preventive Care and Screening: Influenza Immunization
CMS149: Dementia: Cognitive Assessment
CMS153 Chlamydia Screening for Women
CMS154 Appropriate Treatment for Children with Upper Respiratory Infection (URI)
CMS155 Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
CMS156 Use of High-Risk Medications in the Elderly
CMS157: Oncology: Medical and Radiation – Pain Intensity Quantified
CMS159: Depression Remission at Twelve Months
CMS160: Depression Utilization of the PHQ-9 Tool
CMS161: Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS165 Controlling High Blood Pressure
CMS177: Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS249: Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture
CMS347: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
CMS645: Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
CMS771: International Prostate Symptom Score (IPSS) or American Urological Association-Symptom Index (AUA-SI) Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia
AdvancedMD Mobile certification criteria
Certification criteria:
170.315 (a)(1): Computerized Provider Order Entry (CPOE) – Medications
170.315 (a)(2): CPOE – Laboratory
170.315 (a)(3): CPOE – Diagnostic Imaging
170.315 (a)(4): Drug-Drug, Drug-Allergy Interaction Checks
170.315 (a)(5): Demographics
170.315 (a)(12): Family Health History
170.315 (b)(3): Electronic Prescribing
170.315 (b)(10): EHI Export
170.315 (d)(1): Authentication, Access Control, Authorization
170.315 (d)(2): Auditable Events and Tamper-Resistance
170.315 (d)(3): Audit Report(s)
170.315 (d)(4): Amendments
170.315 (d)(5): Automatic Access Time-out
170.315 (d)(6): Emergency Access
170.315 (d)(7): End-User Device Encryption
170.315 (d)(8): Integrity
170.315 (d)(9): Trusted Connection
170.315 (d)(12): Encrypt Authentication Credentials
170.315 (d)(13): Multi-factor authentication
170.315 (g)(3): Safety-Enhanced Design
170.315 (g)(4): Quality Management System
170.315 (g)(5): Accessibility-Centered Design
